BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Kenya Kamimura, Akira Sakamaki, Hiroteru Kamimura, Toru Setsu, Takeshi Yokoo, Masaaki Takamura, Shuji Terai. Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patientsWorld Journal of Gastroenterology 2019; 25(15): 1817-1827 doi: 10.3748/wjg.v25.i15.1817
2
TOMOYUKI NEMOTO, HIDETAKA MATSUDA, TAKUTO NOSAKA, YASUSHI SAITO, YOSHIHIKO OZAKI, RYOKO HAYAMA, TATSUSHI NAITO, KAZUTO TAKAHASHI, KAZUYA OFUJI, MASAHIRO OHTANI, KATSUSHI HIRAMATSU, HIROYUKI SUTO, YASUNARI NAKAMOTO. Comparison of hepatic arterial infusion chemotherapy and sorafenib in elderly patients with advanced hepatocellular carcinoma: A case seriesMolecular and Clinical Oncology 2014; 2(6): 1028 doi: 10.3892/mco.2014.371
3
Akiyoshi Kinoshita, Kazuhiko Koike, Hirokazu Nishino. Clinical features and prognosis of elderly patients with hepatocellular carcinoma not indicated for surgical resectionGeriatrics & Gerontology International 2017; 17(2): 189 doi: 10.1111/ggi.12747
4
Ling-Yun Zhao, Rong-Rui Huo, Xiao Xiang, Guido Torzilli, Ming-Hua Zheng, Tian Yang, Xin-Min Liang, Xi Huang, Pei-Ling Tang, Bang-De Xiang, Le-Qun Li, Xue-Mei You, Jian-Hong Zhong. Hepatic resection for elderly patients with hepatocellular carcinoma: a systematic review of more than 17,000 patientsExpert Review of Gastroenterology & Hepatology 2018; 12(10): 1059 doi: 10.1080/17474124.2018.1517045
5
Giuseppe Cabibbo, Marcello Maida, Calogero Cammà, Antonio Craxì. Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?Expert Review of Anticancer Therapy 2013; 13(12): 1355 doi: 10.1586/14737140.2013.859989
6
Hiroya Iida, Masaki Kaibori, Kosuke Matsui, Morihiko Ishizaki, Masanori Kon. Assessing the feasibility of clinicopathological features of hepatic resection for hepatocellular carcinoma in patients over 80 years of ageMolecular and Clinical Oncology 2017; 6(1): 29 doi: 10.3892/mco.2016.1079
7
Maisa Hori, Masatoshi Tanaka, Eiji Ando, Masahiro Sakata, Shigeo Shimose, Miki Ohno, Shigeru Yutani, Kei Kuraoka, Ryoko Kuromatsu, Shuji Sumie, Michio Sata. Long-term outcome of elderly patients (75 years or older) with hepatocellular carcinomaHepatology Research 2014; 44(9): 975 doi: 10.1111/hepr.12279
8
Kevin Ka Wan Chu, Kenneth Siu Ho Chok. Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients?World Journal of Gastroenterology 2019; 25(27): 3563-3571 doi: 10.3748/wjg.v25.i27.3563